Terns Pharmaceuticals
TERN
TERN
126 hedge funds and large institutions have $447M invested in Terns Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 45 increasing their positions, 24 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
126
Holders Change
+14
Holders Change %
+12.5%
% of All Funds
1.83%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.04%
New
40
Increased
45
Reduced
24
Closed
25
Calls
$3.72M
Puts
$809K
Net Calls
+$2.91M
Net Calls Change
+$2.11M
Top Buyers
1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$33.7M |
2 |
SSA
Schonfeld Strategic Advisors
New York
|
+$7.3M |
3 |
SCM
Superstring Capital Management
New York
|
+$6.51M |
4 |
BlackRock
New York
|
+$5.48M |
5 |
WP
Woodline Partners
San Francisco,
California
|
+$5.07M |
Top Sellers
1 |
Millennium Management
New York
|
-$15.6M |
2 |
Janus Henderson Group
London,
United Kingdom
|
-$13.1M |
3 |
Citadel Advisors
Miami,
Florida
|
-$10.3M |
4 |
SCM
Suvretta Capital Management
New York
|
-$8.95M |
5 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
-$8.79M |